A team of German scientists has developed a new compound that dramatically decreases the damage to neurons in rats exhibiting stroke symptoms.
The research findings are published in the May 26 issue of the Journal of Biological Chemistry. The findings say the immunosuppressive drug FK506 (also known as Tacrolimus or Prograf) that is often given to patients receiving transplants to prevent organ rejection has far reaching medical applications
